National Comprehensive Cancer Network



About NCCN

Adolescent and Young Adult Oncology Panel - Disclosures as of 3/30/2015

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Virginia (Ginger) F. Borges, MD, MMSc

None

None

None

None

None

3/12/2014

Scott C. Borinstein, MD, PhD

None

Consultans, Luvera Law Firm;
Whitlow, Roberts, Houston, and Straub LLC

None

None

None

3/3/2015

Peter F. Coccia, MD

None

None

None

None

None

12/10/2014

Shira Dinner, MD

         

Pending

Joseph Flynn, DO, MPH, FACP

None

None

None

None

None

1/14/2015

Jeanelle Folbrecht, PhD

         

Pending

A. Lindsay Frazier, MD, ScM

None

None

None

None

None

1/15/2015

Robert Goldsby, MD

None

United therapeutics

None

None

None

1/14/2015

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

3/20/2015

Robert Hayashi, MD

None

National Childrens Cancer Society;
Pediatric Cancer Research Foundation

None

None

None

1/15/2015

Mary S. Huang, MD

None

None

None

None

None

2/24/2015

Lynda Kwon Beaupin, MD

None

None

Jazz Pharmaceuticals

None

None

1/26/2015

Michael P. Link, MD

Seattle Genetics

AstraZeneca Pharmaceuticals LP;
Jannsen Pharmaceutica Products, LP

None

None

None

3/3/2015

Joan S. McClure, MS

None

None

None

None

None

12/8/2014

Fred Millard, MD

Bristol-Myers Squibb Company;
Dendreon Corporation;
Eli Lilly and Company;
Exelixis Inc.;
Altor, Inc;
Argos Therapeutics;
Moores UCSD Cancer Center;
sanofi-aventis U.S.

NCCN enzalutamide program

None

None

None

1/14/2015

Kevin C. Oeffinger, MD

None

None

None

None

None

1/14/2015

Kathleen M. Orr, MSW, LCSW-C

None

None

None

None

None

4/9/2014

Alberto S. Pappo, MD

None

None

;
Ziopharm

None

None

1/12/2015

Donna Powell, MS, CMD, RT(T)

None

None

None

None

None

10/1/2014

Damon R. Reed, MD

None

Advaxis;
EMD Serrano

None

None

None

1/14/2015

Steven Robinson, MBBS

None

None

None

None

None

9/25/2014

Abby R. Rosenberg, MD, MS

None

None

None

None

None

2/18/2015

Tara Sanft, MD

Biotheranostics

Biotheranostics

None

None

None

8/25/2014

Dorothy Shead, MS

None

None

None

None

None

2/18/2015

Holly L. Spraker, MD, MS

None

None

None

None

None

1/14/2015

Hema Sundar, PhD

None

None

None

None

None

2/18/2015

Deborah A. Thomas, MD

None

Amgen Inc.;
Spectrum Pharmaceuticals

Amgen Inc.;
Spectrum Pharmaceuticals

None

None

2/5/2014

Margaret von Mehren, MD

;
Eisai Inc.;
Johnson & Johnson;
Merck & Co., Inc.;
Morphotek Inc.;
National Cancer Institute;
Novartis Pharmaceuticals Corporation;
OSI Pharmaceuticals, Inc.;
Arog Pharmaceuticals;
Astex;
Sarcoma Alliance for Research through Collaboration;
Pfizer Inc.;
Synta Pharmaceuticals Corp.

Eisai Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

9/1/2014

Daniel S. Wechsler, MD, PhD

None

None

Hyundai Hope on Wheels;
Jazz Pharmaceuticals;
Sigma-Tau Pharmaceuticals, Inc.

None

None

2/8/2015

Kimberly F. Whelan, MD

None

None

None

None

None

2/25/2015

Bradley J. Zebrack, PhD, MSW, MPH

None

None

Onyx Pharmaceuticals, Inc.

None

None

12/9/2013